Eisai's Antiepileptic Drug Fycompa Injection Formulation Launched In Japan Eisai Apr 17, 2024 15:17 HKT/SGT Read More
中国抗体SM17治疗特应性皮炎(AD)之临床前结果刊登于国际科学期刊《Allergy》 SinoMab BioScience Limited Apr 16, 2024 17:48 HKT/SGT Read More
中國抗體SM17治療特應性皮炎(AD)之臨床前結果刊登於國際科學期刊《Allergy》 SinoMab BioScience Limited Apr 16, 2024 17:44 HKT/SGT Read More
SinoMab BioScience preclinical results of SM17 on atopic dermatitis (AD) published on International Scientific Journal Allergy SinoMab BioScience Limited Apr 16, 2024 17:35 HKT/SGT Read More
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology Autonomix Medical Inc. Apr 16, 2024 17:04 HKT/SGT Read More
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024 NEC Corporation Apr 10, 2024 12:36 HKT/SGT Read More
Chiron AS in Trondheim, Norway, Has Developed The World's First Commercial Microplastic Reference Materials ZeptoMetrix Apr 09, 2024 22:30 HKT/SGT Read More
NEC white paper proposes comprehensive process workflow for the application of AI-driven personalized cancer vaccines NEC Corporation Apr 08, 2024 12:45 HKT/SGT Read More
The $7 Billion CBD Market in 2023 is Focused on Significant Growth in Personal Care Femto Technologies Inc Apr 05, 2024 21:00 HKT/SGT Read More
World Hepatitis Summit 2024 Convenes in Lisbon World Hepatitis Alliance Apr 04, 2024 19:00 HKT/SGT Read More
A $45 Billion Dollars Market is in the Crosshairs of BYND Cannasoft with a New Series of Concept Smart Fem-Tech Devices Femto Technologies Inc Apr 03, 2024 21:30 HKT/SGT Read More
Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% Randomization Clairvoyant Therapeutics Apr 03, 2024 20:00 HKT/SGT Read More
French Sales Subsidiary Eisai S.A.S. to Divest Rights for Loxapac And Parkinane LP to CNX Therapeutics Eisai Apr 03, 2024 15:24 HKT/SGT Read More
Israeli Technology Company BYND Cannasoft Enterprises Inc. Announces Financial Results For The Year Ended December 31, 2023 Femto Technologies Inc Apr 03, 2024 10:00 HKT/SGT Read More
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia China Medical System Holdings Ltd. Apr 01, 2024 21:30 JST Read More
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia China Medical System Holdings Ltd. Apr 01, 2024 20:30 HKT/SGT Read More